This page is the continuation of references in support of Section 6D
REFERENCES
American Cancer Society: Cancer Facts and Figures 2014. Atlanta: American Cancer Society. (Retrieved 19th Feb 2015): http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
Ellis PM, Blais N, Soulieres D et al. (2011). A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer. J Thorac Oncol. 6(8):1379-91. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=21709590
Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5)(suppl):e93S-e120S. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749714/
Grossi F. Management of non-small cell lung in cancer patients with stable disease. Drugs. 2012; 72 Suppl 1:20-27. (Retrieved 19th Feb 2015): http://link.springer.com/article/10.2165%2F1163013-S0-000000000-00000
Kerr KM, Bubendorf L, Edelman MJ, et al. Panel Members. (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol 25(9), 1681-90. (Retrieved 20th Feb 2015): http://annonc.oxfordjournals.org/content/25/9/1681.full.pdf+html
Rami-Porta R, Crowley JJ, Goldstraw P. (2009). The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 15(1), 4–9. (Retrieved 10th Feb 2015): http://www.atcs.jp/pdf/2009_15_1/4.pdf
Rusch VW, Asamura H, Watanabe H, et al. (2009). The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4:568. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/19357537
Sica G, Yoshizawa A, Sima CS, et al. (2010). A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 34(8), 1155–1162. (Retrieved 10th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/20551825
Schreiber G, McCrory DC. (2003). Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 123(1 Suppl), 115S. (Retrieved 19th Feb 2015): (Retrieved 19th Feb 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1081260
Travis WD, Colby TV, Corrin B, et al, eds. Histological typing of lung and pleural tumours. WHO international histological classification of tumours, 3rd ed. Berlin: Springer, 1999.
Travis WD, Brambilla E, Noguchi M, et al. (2011). International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6(2), 244–285. (Retrieved 10th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/21252716
Wang GF, Lai MD, Yang RR et-al. (2006). Histological types and significance of bronchial epithelial dysplasia. Mod. Pathol 19 (3), 429-37. (Retrieved 10th Feb 2015): http://www.nature.com/modpathol/journal/v19/n3/full/3800553a.html
WHO Classification of Tumors of the Lung. 3rd Edition. (Retrieved 10th Feb 2015): http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf
Yi ES, Boland JM, Maleszewski JJ et al. (2011). Correlation of immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH. J. Thorac. Oncol 6,459–465. (Retrieved 19th Feb 2015): http://journals.lww.com/jto/Fulltext/2011/04000/Correlation_of_IHC_and_FISH_for_ALK_Gene.30.aspx
